Back
FibroGen, Inc. 10K Form
Sell
35
FGEN
FibroGen, Inc.
Last Price:
$8.30
Seasonality Move:
26.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-06 | 10Q | FGEN/FibroGen, Inc. Quarterly |
| 2023-08-07 | 10Q | FGEN/FibroGen, Inc. Quarterly |
| 2023-05-08 | 10Q | FGEN/FibroGen, Inc. Quarterly |
| 2022-11-07 | 10Q | FGEN/FibroGen, Inc. Quarterly |
| 2022-08-08 | 10Q | FGEN/FibroGen, Inc. Quarterly |
| 2022-05-09 | 10Q | FGEN/FibroGen, Inc. Quarterly |
Receive FGEN News And Ratings
See the #1 stock for the next 7 days that we like better than FGEN
FGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $29.6M |
|---|---|
| Cash Flow: | $-1.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-4.21 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 39.33790 |
|---|---|
| Net Income (TTM): | $-52.3M |
| Gross Margin: | $14.1M |
| Return on Equity: | 0% |
| Return on Assets: | -27.24% |
FibroGen, Inc. Earnings Forecast
Key FibroGen, Inc. Financial Ratios
-
The Gross Profit Margin over the past 13 years for FGEN is 47.47%.
-
The Selling, General & Administrative Expenses for FGEN have been equal to 166.54% of Gross Profit Margin.
-
The Research & Development expenses have been 323.05% of Revenue.
-
The Net Earning history of FGEN is -516.86% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 8 years.
FibroGen, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | FGEN |
| CUSIP: | 31572Q |
| Website: | fibrogen.com |
Debt
| Debt-to-Equity Ratio: | -1.24 |
|---|---|
| Current Ratio: | 3.71 |
| Quick Ratio: | 3.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
FGEN Technical Analysis vs Fundamental Analysis
Sell
35
FibroGen, Inc. (FGEN)
is a Sell
Is FibroGen, Inc. a Buy or a Sell?
-
FibroGen, Inc. stock is rated a SellThe current FibroGen, Inc. [FGEN] share price is $8.25. The Score for FGEN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.